Piret Lab | Renaissance School of Medicine at Stony Brook University

Meet the research personnel in the Piret Lab

Our overall aim is to understand the molecular and cellular changes that occur in kidney proximal tubules in acute kidney injury (AKI) and progression of AKI to chronic kidney disease (CKD).

Specifically, we are investigating the roles of members of the Krüppel-like factor (KLF) family of transcription factors, in controlling cellular metabolism in normal kidney, and during AKI and CKD.

Why is this important?

In 2014, there were almost 4 million hospitalizations with AKI in people aged 20 and older
Of patients aged 66 and older who were hospitalized with AKI in 2018, >8% died in hospital. Of those that were discharged, the cumulative 1-year incidence of recurrent hospitalization with AKI was >26%, and of death was >31%. Of those who did not have CKD before AKI, >50% went on to develop CKD after 1 year
Of patients aged 20 and older that started outpatient dialysis for AKI treatment in 2018, the cumulative incidence of death at 1 year was >34%
Patients in the ICU may have an incidence of AKI ranging from 20%–50%
There are currently no therapies to treat AKI, reverse its effects, or prevent transition to CKD

Why the proximal tubule?

The proximal tubule is the powerhouse for reabsorption of solutes and proteins by the kidney
AKI may result from diverse causes such as drugs (e.g. chemotherapeutics), environmental toxins, sepsis, ischemia (lack of oxygen). All of these primarily affect the proximal tubule.
Many cellular changes occur in damaged proximal tubules, including changes in morphology, cell cycle, secretome, and cellular metabolism
We have shown that proximal tubular KLFs are critical for determining the cellular response to injury
Mice lacking proximal tubular KLF6 are protected from AKI whereas mice lacking KLF15 have worsened AKI – our current research aims to understand the mechanisms of these effects

Project 1: Role of KLF6 and KLF15 in control of PT cellular metabolism

Our previous data has shown that KLF6 is likely to transcriptionally repress expression of genes involved in branched chain amino acid (BCAA; Val, Leu, Ile) catabolism. and that KLF15 likely cooperates with PPARα to control fatty acid oxidation (FAO). We are studying the mechanisms by which KLF6 and KLF15 may co-operate to regulate BCAA catabolism and FAO, either directly and/or through mTORC1 signaling.

Project 2: Role of BCAA catabolism in severity of and recovery after AKI

BCAA are catabolized in the kidney to generate TCA cycle intermediates, but the significance of these metabolic pathways for kidney function have not previously been explored. We have shown that expression of genes encoding BCAA catabolic enzymes is reduced in various forms of AKI and CKD. We now aim to understand the significance of BCAA catabolism in AKI by undertaking studies in vitro and in vivo to determine whether loss of BCAA catabolism results in increased susceptibility to AKI and/or CKD; and whether activation of BCAA catabolism can protect against AKI and/or CKD.

KEY PUBLICATIONS

Piret SE, Guo Y, Attallah AA, Horne SJ, Zollman A, Owusu D, Henein J, Sidorenko VS, Revelo MP, Hato T, Ma’ayan A, He JC, Mallipattu SK. Krüppel-like factor 6-mediated loss of BCAA catabolism contributes to kidney injury in mice and humans. PNAS (2021) 118: e2024414118.

Piret SE*, Attallah AA*, Gu X, Guo Y, Gujarati NA, Henein J, Zollman A, Hato T, Ma’ayan A, Revelo MP, Dickman KG, Chen CH, Shun CT, Rosenquist TA, He JC, Mallipattu SK. Loss of proximal tubular Krüppel-like factor 15 (KLF15) exacerbates kidney injury through loss of fatty acid oxidation. Kidney International (2021) 100: 1250-67. *joint first authors.

Piret SE, Olinger E, Reed AAC, Nesbit MA, Hough TA, Bentley L, Devuyst O, Cox RD, Thakker RV. Mouse model for inherited renal fibrosis associated with endoplasmic reticulum stress. Disease Models and Mechanisms (2017) 10: 773-86.

Piret SE^a, Gorvin CM^a, Pagnamenta AT, Howles SA, Cranston T, Rust N, Nesbit MA, Glaser B, Taylor JC, Buchs AE, Hannan FM, Thakker RV. Identification of a G-protein Subunit-11 Gain-of-Function Mutation, Val340Met, in a Family With Autosomal Dominant Hypocalcemia Type 2 (ADH2). J Bone Miner Res (2016) 31: 1207-14. ^ajoint first authors

Piret SE, Esapa CT, Gorvin CM, Head R, Loh NY, Devuyst O, Thomas G, Brown SDM, Brown M, Croucher P, Cox R, Thakker RV. A mouse model of early-onset renal failure due to a xanthine dehydrogenase nonsense mutation. PLoS One (2012) 7: e45217.

Williams SE, Reed AAC, Galvanovskis J, Antignac C, Goodship T, Karet FE, Kotanko P, Lhotta K, Morinière V. Williams P, Wong W, Rorsman P, Thakker RV. Uromodulin mutations causing Familial Juvenile Hyperuricaemic Nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum. Hum Mol Genet (2009) 18: 2963-74. [published using maiden name]

Full list of publications: NIH Publications - Piret Bibliography

RECENT FUNDING

NIH-NIDDK 1R01DK133238 (2023-2027): “Role of branched-chain catabolism in the proximal tubule” NIH RePORTER; SBU News

Stony Brook Department of Medicine Pilot Project Grant (2023-2024): “Development of high-throughput assays for screening of novel small molecule therapeutics”

American Heart Association Career Development Award (2022-2025): "Role of branched-chain amino acid catabolism in the proximal tubule"

KidneyCure (American Society of Nephrology) Joseph V. Bonventre Research Scholar Grant (2020-2022)

UAB-UCSD O’Brien Center for Acute Kidney Injury Research Pilot & Feasibility Grant (2018-2020)